Peptide Purity: What Does 99% Actually Mean?
Peptide purity explained: crude vs desalted vs HPLC-purified, how the percentage is calculated under USP 〈621〉, and how pure a research peptide needs to be.
"99% purity" is one of the most-quoted figures in the research-peptide market — and one of the least understood. This guide explains what the number means, how it is calculated, and what the published literature actually says about how pure a peptide needs to be. The findings are summarised here in full, so you should not need to leave this page.
Crude vs desalted vs HPLC-purified
The 2016 consensus recommendations published in Clinical Chemistry (Hoofnagle et al.) draw the line clearly. A purified peptide is one chromatographically purified after synthesis to remove most of the residual salts, synthesis reagents, partially deblocked peptides and truncated sequences. A crude peptide may or may not have had any purification step at all — and the authors are blunt about the consequence: for crude material, neither accurate quantity nor purity are possible. That is the practical difference. It is not that crude peptide is bad; it is that you cannot say what is in it.
Crude — straight from synthesis; contains by-products, and neither its quantity nor its purity can be stated accurately Desalted — counterions and some impurities removed; moderate purity HPLC-purified — chromatographically separated to a defined, measurable purity backed by a chromatogram How the percentage is calculated
Peptide purity is determined from HPLC data under the normalisation procedure in USP General Chapter 〈621〉: the area of the main peak expressed as a percentage of the total area of all the peaks. A figure of 99% means impurities account for roughly 1% of the detected material. Two caveats that rarely make it into marketing: 〈621〉 excludes peaks from solvents, reagents, the mobile phase and the sample matrix, along with anything at or below the disregard limit — and it applies only where linearity of the peaks has been demonstrated. The figure is meaningful only when tied to a specific batch and an actual chromatogram. We cover how to read one in our guide to reading an HPLC purity report .
So how pure does a research peptide need to be?
Honestly: it depends on what you are doing, and anyone quoting you a single universal threshold is quoting marketing rather than a standard. There is no pharmacopoeial or regulatory purity bar for research peptides. The most-cited published consensus — Hoofnagle et al. in Clinical Chemistry — specifies greater than 95% chemical purity for purified peptides used in quantitative work, and greater than 50% for crude material, where the peptide must at least be the highest peak. Even then the authors frame it as fit-for-purpose rather than absolute: crude peptides can legitimately be used for relative quantification in lower-tier assays provided the resulting assay performance is carefully assessed. A 2024 Methods in Molecular Biology chapter (Schnatbaum et al.) makes the same point from the other direction — specific requirements with respect to purity vary depending on the purpose of an assay.
What higher purity buys you is not compliance with a rule. It is a narrower margin for impurity-driven artefacts, and less of your material being something other than what you think you weighed out.
Why impurities matter: the parts that are not the peptide
Impurities introduce variables. Some are intrinsic to how peptides are made: as Schnatbaum et al. put it, because of the way peptides are produced they will always contain certain amounts of impurities such as peptides with deletions or truncated peptides. Those are sequence errors — molecules closely related to your target, which is exactly what makes them hard to separate and easy to overlook.
The counterion is the one most people miss. Solid-phase synthesis leaves peptides as trifluoroacetate (TFA) salts, and TFA is not inert. A 2025 review in Pharmaceuticals (Erckes et al.) records that residual TFA has been shown to increase — and in other work inhibit — cell proliferation, to increase cell and liver toxicity, and to provoke greater antibody-response activation. Their framing is worth repeating: counterions are not passive components. There is also a purely arithmetic problem. The counterion adds mass, so weighing a TFA salt as though it were free peptide overstates how much peptide you actually added.
It is worth being precise about how far this goes, because the honest version is more useful than the alarming one. A 2018 study in Amino Acids (Sikora et al.) compared five antimicrobial peptides as their TFA, acetate and chloride salts and found the lowest antimicrobial activity in the trifluoroacetate salts — but the authors concluded there is no simple correlation between counterion type and biological activity. The effect is real and peptide-dependent. The takeaway is not that TFA ruins experiments; it is that the counterion is a variable that should be known and reported rather than assumed away.
What to ask any supplier
Is the purity figure batch-specific? Is there an HPLC chromatogram, not just a number? Is identity confirmed by mass spectrometry? Purity does not establish identity What is the counterion, and is its content stated? Who performed the testing, and are they independent? The Vivera standard
Vivera peptides are USA-manufactured and tested by an independent US-based third-party laboratory, with a batch-specific Certificate of Analysis available on request. All products are supplied for in-vitro laboratory research use only.
Frequently Asked Questions What is the difference between crude, desalted and HPLC-purified peptides? A crude peptide comes straight from synthesis and contains by-products, and neither its quantity nor its purity can be stated accurately. A desalted peptide has counterions and some impurities removed for moderate purity, while an HPLC-purified peptide is chromatographically separated to a defined, measurable purity backed by a chromatogram.
How is peptide purity percentage calculated? Purity is determined from HPLC data under the normalisation procedure in USP General Chapter 〈621〉: the area of the main peak expressed as a percentage of the total area of all the peaks. So a figure of 99% means impurities account for roughly 1% of the detected material. The figure is meaningful only when tied to a specific batch and an actual chromatogram, and you can see how to read one in our guide to reading an HPLC purity report .
How pure does a research peptide need to be? It depends on the application, and there is no pharmacopoeial or regulatory purity bar for research peptides. The most-cited consensus, Hoofnagle et al. in Clinical Chemistry, specifies greater than 95% chemical purity for purified peptides used in quantitative work and greater than 50% for crude material, but frames purity as fit-for-purpose rather than an absolute threshold.
Why does the counterion matter in a peptide? Solid-phase synthesis leaves peptides as trifluoroacetate (TFA) salts, and TFA is not inert. A 2025 review in Pharmaceuticals reports residual TFA has been shown to affect cell proliferation and to increase cell and liver toxicity in laboratory studies, and because the counterion adds mass, weighing a TFA salt as though it were free peptide overstates how much peptide you actually added.
Related
Continue reading
For in-vitro laboratory research use only. Not for human or veterinary use, consumption, or therapeutic application. No medical claims are made.
